Mixed strategies produce mixed results

10 June 2014 - Deborah Wilkes


The business environment in the first quarter of 2014 proved difficult for many branded OTC players, according to the new OTC Results Comparisons Briefing just published by OTCToolbox. Several companies – including Bayer, GlaxoSmithKline, Johnson & Johnson, Merck KGaA, Novartis and Pfizer – highlighted the lower incidence of colds and flu compared with the first quarter of 2013.

Annual Subscription Holder?

Sign in to continue reading.

Sign In

Back to Industry News

Share this page: